BAL-0105277

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBAL-0105277
Drug Alias NameBAL-0105277
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodieterase 4 inhibitors
TargetsPhosphodieterase 4
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBasilea Pharmaceutica
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBasilea Pharmaceutica
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A